Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Nobelpharma
Nobelpharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Hyftor
Sirolimus
2022-03-22
2029-2040
Kidney transplantation
,
Lymphangioleiomyomatosis
,
Perivascular epithelioid cell neoplasms
,
Graft rejection
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sirolimus
neoplasm metastasis
,
port-wine stain
,
capillary hemangioma
,
triple negative breast neoplasms
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
t-cell lymphoma peripheral
,
lymphoid leukemia
,
sarcoma
,
osteosarcoma
,
pancreatic neoplasms
,
lung neoplasms
,
brain neoplasms
,
glioma
,
astrocytoma
,
oligodendroglioma
,
tuberous sclerosis
,
angiofibroma
,
facies
,
neoplasms
,
recurrence
,
head and neck neoplasms
,
multiple myeloma
,
colorectal neoplasms
,
squamous cell neoplasms
,
non-small-cell lung carcinoma
,
glioblastoma
,
squamous cell carcinoma
,
nasopharyngeal neoplasms
,
multiple hamartoma syndrome
,
hamartoma
,
hemangioma
,
kaposi sarcoma
,
kasabach-merritt syndrome
,
hemangioendothelioma
,
hepatocellular carcinoma
,
liver neoplasms
,
chronic kidney failure
,
pulmonary vein stenosis
,
pathologic constriction
,
endometrial neoplasms
,
fibroma
,
desmoid tumors
,
thyroid neoplasms
,
thyroid diseases
,
central nervous system neoplasms
,
nervous system neoplasms
,
systemic lupus erythematosus
,
adenocarcinoma
,
renal cell carcinoma
,
carcinoma
,
breast neoplasms
,
kidney neoplasms
,
syndrome
,
urogenital neoplasms
,
renal insufficiency
,
carotid artery diseases
,
atherosclerosis
,
brain stem infarctions
,
sturge-weber syndrome
,
klippel-trenaunay-weber syndrome
,
cognitive dysfunction
,
kidney transplantation
,
lymphoma
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
,
graft rejection
,
inflammation
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
islet cell adenoma
,
kidney diseases
,
viremia
,
atrial fibrillation
,
atrial flutter
Regramostim
prostatic neoplasms
,
neoplasms
,
lung neoplasms
,
malignant mesothelioma
,
mesothelioma
,
multiple myeloma
,
ovarian neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
Molgramostim
aids-related complex
,
aggression
,
ovarian neoplasms
,
neuroblastoma
,
central nervous system neoplasms
,
germ cell and embryonal neoplasms
,
liver neoplasms
,
nervous system neoplasms
,
non-hodgkin lymphoma
,
hiv infections
,
multiple myeloma
,
neutropenia
,
lymphoma
,
plasma cell neoplasms
,
hodgkin disease
,
sarcoma
,
acquired immunodeficiency syndrome
,
lung neoplasms
,
myeloid leukemia acute
,
myeloid leukemia
,
neoplasms
,
pancytopenia
,
cytopenia
,
non-small-cell lung carcinoma
,
prostatic neoplasms
,
pain
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
oncogenes
,
bone neoplasms
,
type 1 diabetes mellitus
,
smoldering multiple myeloma
,
myeloproliferative disorders
,
hematologic diseases
,
aplastic anemia
,
blast crisis
,
kaposi sarcoma
,
breast neoplasms
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
melanoma
,
graft vs host disease
,
b-cell lymphoma
ARBEKACIN
duchenne muscular dystrophy
,
muscular dystrophies
Aspartame
opioid-related disorders
Bevifimod
type 1 diabetes mellitus
,
graft rejection
,
alpha 1-antitrypsin deficiency
,
emphysema
,
pulmonary emphysema
,
graft vs host disease
Nepidermin
hypercholesterolemia
,
dyslipidemias
Retinol
alopecia
,
acne vulgaris
,
skin care
Sagramostim
breast neoplasms
,
male breast neoplasms
,
lymphoma
Tisseel
tympanic membrane perforation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use